Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q3 EPS of ($0.33), $0.51 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c